News

Nestlé Health Science has entered into an agreement to buy Aimmune Therapeutics, the company that developed and launched the only FDA-approved treatment for peanut allergy. Palforzia® is an oral immunotherapy designed to help reduce the frequency and severity of allergic…

The National Allergy Strategy has developed and launched a new ‘All about Allergens’  free online training program for hospital food service providers, ward staff and volunteers. The new training program was launched by the Hon Greg Hunt, Minister for Health,…

Independent reviewers have assessed the research activities of the UK Food Standards Agency’s (FSA) Food Allergy and Intolerance Research (FAIR) program. The draft report has prompted several interim recommendations that will help determine the way government-commissioned research into food hypersensitivity is…

We know that aiming for zero risk from unintended allergens for food‐allergic people is not realistic, yet to-date there is no consensus about what level of risk is acceptable. In a recent journal article, a collective of experts in this…

It was previously thought best to delay the introduction of key allergenic foods like peanut and egg at least until after a child’s first birthday. Evidence now suggests that introducing such foods in the first 6-12 months reduces allergy risk.…

The allergy-protective effects of exposure to dirt and ‘germs’ during childhood is a key part of the hygiene hypothesis that aims to explain why allergies are now more prevalent than ever. Several past studies have shown children who grow up…